Zobrazeno 1 - 10
of 23
pro vyhledávání: '"V. A. Elykomov"'
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 19, Iss 2 (2020)
In modern medical practice, contrast-induced nephropathy (CIN) is an urgent problem in patients with acute coronary syndrome that underwent percutaneous interventions. It worsens prognosis, increases the number of cardiovascular complications and the
Externí odkaz:
https://doaj.org/article/27fb566450dd4fbc853db437e7ef2fd0
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 17, Iss 6, Pp 13-19 (2018)
Aim. To study the clinical features and risk factors (RF) associated with the development of acute coronary syndrome (ACS) in young patients.Material and methods. The study included 474 patients with ACS. Depending on age, patients were divided into
Externí odkaz:
https://doaj.org/article/c1f0ffb67373421bbd6217a7c900bc4c
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 5, Pp 34-39 (2018)
Aim. To assess the preoperational risk factors (RF) most significantly related to coronary arteries (CA) restenosis in postmenopausal women with obesity.Material and methods. To the study, 94 women included, age 44-70 y.o. (55,44±6,3 y.o.) with obes
Externí odkaz:
https://doaj.org/article/d2a4fac0339246ce9ca0a2c29c985862
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 3, Pp 25-29 (2017)
Aim. To evaluate the results of the program for management of ischemic heart disease registry in Altaisky kray in 2011-2015 y.Material and methods. The system was developed and implemented in 2011 as a pilot project, with software named “Monitoring
Externí odkaz:
https://doaj.org/article/4a02fdaf163240afb8f4cefc6fc07105
Autor:
V. A. Elykomov, A. N. Kopylov
Publikováno v:
Klinicist, Vol 10, Iss 2, Pp 50-54 (2016)
Objective: to identify the possible factors of thrombogenic risk and ways of its prevention in patients with von Willebrand disease.Case description. Patient X., 42 years old, who suffers from von Willebrand disease type 3 with 5-years of age. Asked
Externí odkaz:
https://doaj.org/article/35f24e27d6a54891a194e4dd8f5b73c6
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 15, Iss 2, Pp 32-37 (2016)
Aim. To study prevalence of cardiovascular, respiratory, urinary tract and gastrointestinal comorbidity for the improvement of prediction of complications and adverse outcomes in coronary bypass surgery in patients with coronary heart disease, incl.
Externí odkaz:
https://doaj.org/article/c3c7789c5d294a6aa8974f643cbd0226
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 14, Iss 1, Pp 63-69 (2015)
Aim. Implement the chronic ischemic heart disease (CHD) registry in Altaisky Krai as a system for CHD patients monitoring, and the first results of its work.Material and methods. As a basement for the registry development we used actual Federal and r
Externí odkaz:
https://doaj.org/article/1284914a602c4755b19cfabe8c4ef57d
Autor:
N. G. Veselovskaya, G. A. Chumakova, V. A. Elykomov, O. V. Gritsenko, A. A. Dashkova, E. V. Trubina, E. V. Kiseleva
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 12, Iss 3, Pp 4-9 (2013)
Aim. To assess the role of epicardial obesity (O) and other metabolic factors in the development of coronary artery (CA) restenosis after CA stenting.Material and methods. The study included 68 men with coronary heart disease (CHD), Functional Class
Externí odkaz:
https://doaj.org/article/080ba79bd82244509d1df0ef7a175583
Autor:
V. G. Yarkova, A. V. Bocharova, I. V. Bakhareva, Alexandra Balitskaya, K. V. Klester, E. B. Klester, V. A. Elykomov, Ya. N. Shoykhet, K. N. Zhuravlev
Publikováno v:
PULMONOLOGIYA. 30:756-763
Objective : to assess pulmonary hemodynamics and the presence of systolic and/or diastolic dysfunction of the myocardium of the right and left ventricles in patients with COPD, depending on the risk groups (A, B, C, D); to determine the possible dire
Publikováno v:
Kazanskij Medicinskij Žurnal, Vol 100, Iss 5, Pp 785-790 (2019)
Aim. To estimate in dynamics the changes in muscle strength of hand flexors, muscle mass and gait rate in men with ischemic heart disease and myocardial infarction during cardiac rehabilitation at the outpatient polyclinic stage where daily dosed wal